Background: Green tea (GT) extract may play a role in body weight regulation. Suggested mechanisms are decreased fat
Introduction
Green tea (GT) 5 has been shown to have energy expenditurepromoting effects, because it is rich in polyphenols, mainly catechins, which might play a role in body weight regulation. GT is made from the fresh leaves of Camellia sinensis L. and contains 10-20% catechins (1) . The main GT catechins are epicatechin, epicatechin gallate, epigallocatechin, and epigallocatechin-3-gallate (EGCG), with EGCG being the most abundant catechin. GT catechins have been reported to induce weight loss (2-6) and body fat loss (2, 4, 5) as well as to increase fat oxidation (7, 8) and energy expenditure in short-term (7) (8) (9) (10) and long-term (11) studies. The inhibition of catechol-O-methyltransferase (COMT) by catechins has been proposed to be the principal mechanism behind these effects (12) . GT also contains caffeine, which stimulates thermogenesis and fat oxidation (13, 14) via inhibition of the enzyme phosphodiesterase (15) . The thermogenic effects of GT have been shown to be the result of a combined effect from catechins and caffeine (7) .
However, another important mechanism behind the antiobesity effects of GT catechins may be a decrease in dietary fat absorption, as inferred from increases in fecal fat excretion in rats (16) (17) (18) . In addition, in humans, increased fecal fat excretion after a 10-d treatment with a catechin-enriched beverage was observed (19) . Catechins may attenuate lipid emulsification, which, in the absence of catechins, reduces lipid droplet size and increases the number of droplets, thus improving the digestion of TGs by lipases. However, catechins may also inhibit the activity of gastric and pancreatic lipases (20) . Therefore, impeding both lipid emulsification and lipid digestion might cause a decrease in dietary fat absorption, which results in an increase in fecal fat excretion, thereby reducing digestion efficiency.
At present, most studies assessing the mechanisms of GT catechins with regard to the treatment of obesity are related to sparing fat-free body mass and sustaining energy expenditure despite a negative energy balance (21, 22) . Here, we investigated the possible prevention of overweight by assessing long-term effects of catechinand caffeine-rich GT on dietary fat absorption in humans. We examined whether GT supplementation for 12 wk has beneficial effects on weight control via a reduction in dietary lipid absorption, as well as an increase in resting energy expenditure (REE). The timing of the study was based on several animal studies in which fat and energy absorption was measured over the long term (16) (17) (18) . To examine dietary lipid absorption we assessed fecal fat content (FFC) and fecal energy content (FEC). Physical activity was measured to assess whether subjects maintained their habitual activity. We hypothesized that a 12-wk GT supplementation of 9 GT capsules/d (>0.06 g EGCG + 0.03-0.05 g caffeine per capsule) in energy balance increases fecal fat excretion and REE, resulting in a possible decrease in body weight.
Methods
Subjects were recruited by advertisements on notice boards at Maastricht University and in local newspapers. Sixty-five healthy, normal-weight [BMI (kg/m 2 ): [18] [19] [20] [21] [22] [23] [24] [25] or overweight/obese (BMI $25) Caucasian subjects were included in the study. Subjects were 11 men and 54 women, aged between 18-50 y. During screening, subjects completed questionnaires related to health, smoking behavior, use of medication, alcohol and caffeine consumption, physical activity, and eating behavior. Both men and women were included in order to possibly apply the findings to the general population.
All subjects were nonsmoking, healthy, weight stable (weight change <3 kg during the past 6 mo), not consuming a more than moderate amount of alcohol (<10 drinks/wk) or caffeine (<100 mg/d), and were not using antibiotics during the past 6 mo. The Three-Factor Eating Questionnaire (TFEQ) was used to determine eating behavior (23) . The TFEQ measures the 3 factors involved in eating behavior as follows: cognitive restraint of eating (factor 1), disinhibition (factor 2), and hunger (factor 3). On the basis of median TFEQ scores in the southern part of The Netherlands, nonrestrained eaters (<10 times factor 1) were selected; these are individuals who are not consciously occupied with food and who are not energy restricted. TFEQ was only measured at baseline, as it was used to exclude restrained eaters from participation. Subjects were not taking medications except for the use of oral contraceptives in women.
Subject sample size was calculated with an a of 0.05, a b of 0.95, and a mean 6 SD of 19.3 6 12.9 g for polyphenol-enriched oolong tea and 9.4 6 7.3 g for the control by using total fecal lipid excretion (g/3 d) data from a previous study to calculate the effect size (19) . Sample size was calculated as 25 subjects per group. By taking a dropout into account, the sample size was finalized at 60 subjects.
Written informed consent was obtained from all of the participants. This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and the Medical Ethics Committee of the Academic Hospital in Maastricht approved the study.
Study protocol. The study was conducted in a randomized, placebocontrolled, single-blind design with 2 randomly sequenced experimental groups (GT and placebo). Subjects visited the university twice (baseline and 12 wk). Subjects were asked to travel by public transport or car to avoid physical activity that would increase their REE. They arrived in a fasted state at 0830 h and voided their bladder before anthropometric and REE measurements. After baseline measurements, subjects received either GT or placebo in capsule form, which they had to consume daily for a period of 6 weeks. Six weeks after baseline, subjects received new capsules, which they had to consume daily for the last 6 weeks of the intervention. Dosage. After baseline measurements, subjects received either capsules with GTextract (containing >0.06 g EGCG and 0.03-0.05 g caffeine per capsule) or placebo capsules (Supplemental Table 1 ), which they consumed daily for 12 wk. Subjects were randomly divided into the 2 groups. They were instructed to consume 9 capsules/d: 3 capsules between breakfast and lunch, 3 capsules between lunch and dinner, and 3 capsules >2 h after dinner. Subjects were instructed not to consume the capsules simultaneously with their meals in order to prevent confounding effects of the macronutrients. The GT extract Sunphenon 70H-T was used (Taiyo Kagaku Co. Ltd.). Dutch BioFarmaceutics B.V. encapsulated the GT and placebo components. The capsules with GT are intended for use as a dietary supplement. In the placebo capsules the GT extract was replaced with microcrystalline cellulose (0.27 g/capsule in the GT capsules vs. 0.38 g in the placebo capsules). Microcrystalline cellulose is refined wood pulp and is often used in vitamin supplements. The capsules all had the same appearance. Compliance to capsule intake was checked by asking subjects to return all remaining capsules after 6 and 12 wk. The bioactivity of the GT capsules was tested previously in a randomized crossover experiment by Hursel and Westerterp-Plantenga (24) in which comparable GT from Sunphenon was used. The bioactivity of the GT was shown as energy expenditure significantly increased 3.5 h after ingestion of GT vs. placebo. In addition, to test the bioactivity of the actual GT capsules we first tested GT-induced thermogenesis. Before the ingestion of the GT capsules, REE was measured over 20 min and was 4.0 6 0.7 kJ/min. After ingestion of 3 GT capsules, energy expenditure was measured for another 3.5 h. Energy expenditure increased by 0.3 6 0.1 kJ/min after the ingestion of GT vs. placebo capsules and resulted in an increase of 8.5 6 1.7% compared with REE (P < 0.001).
Body composition. Body weight was measured at baseline and after 12 wk by using a digital balance and height by a wall-mounted stadiometer. BMI was calculated as body weight (kg) divided by height (m) squared. Fat mass was determined by Bod Pod (Life Measurement, Inc) measurements (air displacement plethysmography) (25) . Fat mass index was calculated by fat mass (kg) divided by height (m) squared. BMI, percentage body fat, and fat mass index were used to define body composition. Waist and hip circumferences were determined in standing position by a tape measure. Waist circumference was measured at the smallest circumference between the rib cage and iliac crest, and hip circumference was measured at the level of the anterior superior iliac spine. Accordingly, waist-to-hip ratio (WHR) was calculated by dividing waist by hip circumference. Both waist circumference and WHR were used to define different patterns of body fat distribution.
REE. REE and respiratory quotient (RQ) were measured by means of an open-circuit ventilated hood system. After 30 min of rest, participantsÕ REE was measured in the morning in a fasted state while lying supine for 30 min. Gas analyses were performed by a paramagnetic oxygen analyzer 0-25% (type 1155; Servomex) and an infrared carbon dioxide analyzer 0-1% (type 1520; Servomex). Calculation of REE was based on Long-term effects of green tea on fat absorption 865 the equation of Weir (26) . RQ was calculated as carbon dioxide produced/oxygen consumed. Fat and carbohydrate oxidation per 20 min was measured with the formula of Carpenter in Brouwer (27) . Once per week, the reliability of the ventilated-hood system was validated with a methanol test, with methanol burning during 20 min.
FFC. Fecal samples were collected for the analysis of fat excretion. All feces excreted were collected in preweighed plastic containers during 3 d before each visit, because reference values based on 3 3 24 h feces are representative of mean feces production and values based on 1 3 24 h are affected by individual fluctuations. Before analysis, the fecal samples were homogenized. For each subject, samples from the same period were pooled. Total fecal fat was analyzed according to the following principle. TG, an ester derived from glycerol and 3 FAs, was hydrolyzed with a 33% potassium hydroxide solution in ethanol. After hydrolysis, the added potassium hydroxide was neutralized with the use of hydrochloric acid. The de-esterified FAs were isolated by extraction with toluene and subsequently were directly determined in toluene by acid-base titration with tetrabutyl ammonium hydroxide and bromothymol blue as indicator (28, 29) .
FEC. Before analysis, the fecal samples were weighed and freeze-dried. Fecal energy was obtained by using an adiabatic bomb calorimeter (IKA-Werke GmbH & Co. Kg. calorimeter system C200). Oxidation took place in a closed volume (the bomb) at a well-defined initial temperature. The heat produced during oxidation increased the temperature of the bomb, and the energy released during oxidation was calculated from this temperature increase. Bombs were calibrated by using benzoic acid before use. Digestive efficiency, expressed as percentage of usable energy intake, was calculated as the difference between energy intake and FEC expressed as percentage of the energy intake.
Energy intake and food choice. Subjects were asked not to change their food intake pattern during the 12-wk period. They were instructed to abstain from GT and to use <100 mL caffeine-containing beverages/d. Furthermore they were asked not to use dairy products within 2 h after/ before ingestion of the capsules, because consumption of milk protein inhibits the effect of GT on diet-induced thermogenesis (30) . During the 4 consecutive days before baseline, subjects were asked to maintain their food intake pattern and to record all of the food and drinks they consumed in order to be able to consume exactly the same foods and drinks during the 4 d before their final measurements at week 12. Subjects were stratified by low/normal fat intake (#35% of energy) vs. high fat intake (>35% of energy) to examine the effects of GT on the basis of dietary fat intake.
Physical activity. Physical activity was measured in a subgroup of 23 subjects. Subjects in this subgroup were randomly selected and stratified by gender, age, and BMI. The subjects were instructed to maintain their habitual activity level throughout the entire study period. Physical activity was determined with the use of a DirectLife triaxial accelerometer for movement registration (TracmorD; Philips New Wellness Solutions) during 2 occasions (1 wk before baseline and week 11). The Tracmor is a small device (7 3 2 3 0.8 cm, 30 g), which measures accelerations in the anteroposterior, medio-lateral, and vertical directions of the trunk (31) . Subjects wore the accelerometer during waking hours in a belt at the lower back. Tracmor output was expressed as activity counts per minute. The activity counts per minute were summed over the entire monitoring period and divided by the number of monitoring days to determine the average counts per day (in kilocounts). Physical activity level (PAL) was measured with a model developed to predict PAL. The regression equation was given by PAL = 1.354 + 256 3 10 29 3 counts/d (32).
Statistical analysis. The Statistical Package for the Social Sciences 20.0 (SPSS) was used to test the long-term effects of GT on FFC, FEC, REE, body composition, and physical activity. Both groups were stratified according to the number of men and women, BMI, and age, and the differences between these groups were checked with the use of a factorial ANOVA. P values for these differences were >0.90 for sex distribution and BMI, >0.80 for age, and >0.50 for body weight. Repeated-measures ANOVA was used to determine possible differences in measurements between the 2 groups (GT vs. placebo), between the different time points (baseline and 12 wk after the initiation of the GT or placebo), and the interaction effect (group 3 time). Changes within groups were compared between groups. GT given at the same specific dose likely has varying effects on metabolism and absorption in each individual. Therefore, individual results were clarified by showing the number of subjects in whom GT had a desirable effect (responders) vs. subjects in whom this desirable effect of GT was not found (nonresponders). All statistical tests were 2-sided, and differences were considered significant if P < 0.05. Values are expressed as means 6 SDs.
Results
Subject characteristics. Sixty-five healthy subjects started the experiments; 5 dropped out due to scheduling problems, leaving a total of 60 subjects (50 women, 10 men) who completed both test days (Figure 1 ). Subjects were randomly assigned and stratified by BMI, age, and gender. Groups did not significantly differ at baseline ( Table 1 ). There were no significant differences in the response to GT between men and women.
Compliance. Compliance was checked by counting the leftover and returned capsules. Subjects in the GT group returned 2.9 6 1.8 capsules/wk and subjects in the placebo group returned 3.0 6 1.7 capsules/wk, with no difference in returned capsules between the groups.
Body composition. In subjects who received GT, body weight increased in 14 of 30 subjects and decreased in 15 of 30 subjects, and in 1 subject body weight did not change between baseline and week 12. In the placebo group, body weight increased in 14 of 30 subjects, decreased in 14 of 30 subjects, and did not change between baseline and week 12 in 2 subjects. No significant differences between groups (GT vs. placebo) and no changes over time (baseline vs. week 12) were observed for body weight, body fat percentage, and WHR (Table 1 ). There were no significant differences in the response to GT between subjects with a BMI of 18-25 and subjects with a BMI >25 (Supplemental Table 2 ).
REE. No significant differences were observed between GT (n = 26) and placebo (n = 25) for REE, RQ, fat oxidation, and carbohydrate oxidation ( Table 2) . With respect to possible responders and nonresponders, in 11 of 26 subjects receiving GT REE increased from week 0 to week 12, whereas in 15 of 26 subjects receiving GT REE decreased from week 0 to week 12. In the placebo group, 13 of 25 subjectsÕ REE increased from week 0 to week 12, whereas in 12 of 25 subjects REE decreased over this period of time. Fat oxidation and carbohydrate oxidation (g/20 min) were not significantly different between GT and placebo, and no significant changes over time (baseline vs. week 12) were observed.
FFC and FEC. Energy content of the dry stool did not differ significantly between GT and placebo. No significant differences between groups (GT vs. placebo) and no changes over time (baseline vs. week 12) were observed ( Table 2 ). In the GT group, FFC increased in 18 of 30 subjects and decreased in 12 of 30 subjects; in the placebo group, FFC increased in 16 of 30 subjects and decreased in 14 of 30 subjects. FEC and digestive efficiency (percentage of usable energy intake) were not significantly different between GT and placebo groups, and no significant changes over time (baseline vs. week 12) were observed.
Energy intake and food choice. Mean reported energy and fat intakes did not differ significantly between groups ( Table 3) . There were no significant differences in the response to GT between subjects with a relatively high fat intake (>35% of energy) and subjects with a relatively low fat intake (#35% of energy).
Physical activity. There were no significant differences between both groups at baseline. No significant differences between GT (week before baseline: 1.16 6 0.34 kilocounts/min; week 11: 1.10 6 0.30 kilocounts/min; n = 13) and placebo (week before baseline: 1.20 6 0.26 kilocounts/min; week 11: 1.04 6 0.28 kilocounts/min; n = 10) and no significant changes over time (week before baseline vs. week 11) were observed. PAL was not significantly different between GT (week before baseline: PAL value of 1.79 6 0.13; week 11: PAL value of 1.75 6 0.12) and placebo (week before baseline: PAL value of 1.80 6 0.10; week 11: PAL value of 1.74 6 0.10).
Discussion
Because no significant differences between groups (GT vs. placebo) and no significant changes over time (baseline vs. week 12) were observed for body weight, body composition, REE, fat oxidation, and fat absorption, this study shows that long-term catechin-and caffeine-rich GT supplementation has no longterm effects in healthy, normal-weight and overweight subjects. Nevertheless, previous studies conducted in Asians showed that administration of GT catechins for 12 wk (2, 5) or for 90 d (4) reduced body weight and body fat (2, 4, 5) . However, in an 87-d study in Caucasians, no additional body weight loss with the administration of GT catechins was observed (33) .
The difference between studies in Asian and Caucasian populations may be explained by differences in 1) body composition, because Asians have a higher body fat percentage than do Caucasians with the same BMI (34); 2) dietary habits; and 3) genetic background. The latter may be explained by different single nucleotide polymorphisms of the functional COMT Val108/158Met polymorphism between ethnic groups, with a higher frequency of the high-activity enzyme, COMT H genotype (Val/Val polymorphism), in Asians and a higher frequency of the low-activity enzyme, COMT L genotype (Met/Met polymorphism), in Caucasians. This may play a role in the difference in sensitivity to GT with respect to energy expenditure and fat oxidation (35) . Yet, within the present GT group the division between responders and nonresponders is similar to that in the placebo group, so this cannot be concluded from the present observation. The difference in variety in COMT enzyme activity between species, with higher activity in rats and lower activity in humans (36) , could also explain the differences between the current study and the study by Raederstorff et al. (18) . With respect to GT catechin-induced energy expenditure, we confirmed the finding of previous studies that showed an immediate increase over a short period (7-10), but we did not find any increase in REE over the long term. Diepvens et al. (37) showed that REE as a function of FFM was maintained in the GT group but was significantly reduced in the placebo group over 32 d. However, in this study, subjects followed a low-energy diet, which may imply that the effect of GT on REE is triggered by energy restriction. Measuring REE only in energy balance might be too weak to show an effect.
Similar to Diepvens et al. (37), we did not find an effect of GT catechins on fat oxidation in the long term. In short-term studies, fat oxidation did increase (7, 8) ; therefore, the effect of GT on fat oxidation seems to be acute. The dose in our study was higher than in the other studies (7, 8, 33) , which might have caused habituation.
In another long-term study, Westerterp-Plantenga et al. (22) showed that a mixture of EGCG and caffeine was associated with greater weight maintenance in habitual low caffeine consumers, which was supported by relatively greater thermogenesis and fat oxidation. Here the difference with the present study is the design: weight maintenance after diet-induced weight loss vs. possible weight loss only by GT administration.
In several animal studies beneficial effects of GT polyphenols on fat absorption and body composition were found when combined with a high-fat diet (18, 38) . With respect to the possible GT catechin-induced reduction in fat absorption, Raederstorff et al. (18) investigated the effect of GT catechins on lipid metabolism in rats fed a high-fat diet. They showed that EGCG increased fecal fat excretion. Likewise, Hsu et al. (19) found that polyphenol-enriched oolong tea increased fecal fat excretion when subjects consumed a high-fat diet. In the current study, subjects were asked not to change their food intake pattern; therefore, a possible explanation of the different results between the current study and the above-mentioned studies might be that the effect of catechins only occurs when combined with a high-fat diet. However, we also did not find significant differences in the response to GT between subjects with a relatively high fat intake (>35% of energy) and subjects with a relatively low fat intake (#35% of energy). Furthermore, we used GT whereas Hsu et al. used oolong tea with polymerized polyphenols. GT is nonfermented and nonoxidized, whereas oolong tea is semioxidized and semifermented. Most likely there is a difference in catechin composition between the interventions in both studies. Although it remains controversial whether increasing the dosage of EGCG leads to greater effect, the dosage might have contributed to the differences in results. The use of capsules with a GT extract in this study vs. tea beverages in the study by Hsu et al. is another discrepancy, which may have had an effect on the bioavailability of catechins. The caffeine content of the beverages also differed between studies; Hsu et al. provided 0.13 g/d, whereas the caffeine content in our study was 0.28-0.45 g/d. The role of caffeine in fat absorption is not yet known. Caffeine does not have an effect on lipase activity (39) . However, it has been shown that caffeine may increase colonic activity (40) , which may shorten the presence of food in the gut, and a shorter transit time decreases fat absorption (41) (42) (43) (44) . Taken together, supplementation of GT extract for 12 wk did not have a significant effect on FEC, FFC, REE, RQ, and body composition.
